
Urihold 50mg Tablet ER
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Mirabegron (50mg)
Overview Urihold 50mg Tablet ER
To alleviate overactive bladder symptoms such as frequent urination, urgency, and incontinence, physicians prescribe Urihold 50mg Extended-Release tablets. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your doctor's prescribed dosage and duration. Urihold 50mg ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your physician immediately. Before starting Urihold 50mg ER, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.
Primary Ingredients of Urihold 50mg Tablet ER
No information provided. Please provide the text you wish to be rewritten.
Uses of Urihold 50mg Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Urihold 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Urihold 50mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
Common Side effects of Urihold 50mg Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Urihold 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Urihold 50mg Extended-Release tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistent timing is recommended for best results.
How Urihold 50mg Tablet ER works:
Urihold 50mg Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's mechanism of action involves stimulating bladder receptors, resulting in detrusor muscle relaxation and reduced urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Urihold 50mg extended-release tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Urihold 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Urihold 50mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingSAFE
Extended-release Urihold 50mg tablets typically do not impair driving ability.
KidneyCAUTION
Extended-release Urihold 50mg tablets require careful administration in individuals with significant renal impairment. Dosage modification of Urihold 50mg ER tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Urihold 50mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Urihold 50mg Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Urihold 50mg Tablet ER :
Should you forget to take a Urihold 50mg Extended-Release Tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Urihold 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urologic Care |
| Behavioral Class | Beta-3 agonist for bladder control |
